Van Houdt WJ - Search Results

1

Comparative proteomics of colon cancer stem cells and differentiated tumor cells identifies BIRC6 as a potential therapeutic target.

Van Houdt WJ, Emmink BL, Pham TV, Piersma SR, Verheem A, Vries RG, Fratantoni SA, Pronk A, Clevers H, Borel Rinkes IH, Jimenez CR, Kranenburg O. Van Houdt WJ, et al. Mol Cell Proteomics. 2011 Dec;10(12):M111.011353. doi: 10.1074/mcp.M111.011353. Epub 2011 Jul 25. Mol Cell Proteomics. 2011. PMID: 21788403 Free PMC article.

2

Transient infection of freshly isolated human colorectal tumor cells by reovirus T3D intermediate subviral particles.

van Houdt WJ, Smakman N, van den Wollenberg DJ, Emmink BL, Veenendaal LM, van Diest PJ, Hoeben RC, Borel Rinkes IH, Kranenburg O. van Houdt WJ, et al. Among authors: van den wollenberg dj, van diest pj. Cancer Gene Ther. 2008 May;15(5):284-92. doi: 10.1038/cgt.2008.2. Epub 2008 Feb 8. Cancer Gene Ther. 2008. PMID: 18259212

3

Prolonged portal triad clamping during liver surgery for colorectal liver metastases is associated with decreased time to hepatic tumour recurrence.

Nijkamp MW, van der Bilt JD, Snoeren N, Hoogwater FJ, van Houdt WJ, Molenaar IQ, Kranenburg O, van Hillegersberg R, Borel Rinkes IH. Nijkamp MW, et al. Among authors: van houdt wj, van hillegersberg r, van der bilt jd. Eur J Surg Oncol. 2010 Feb;36(2):182-8. doi: 10.1016/j.ejso.2009.10.016. Epub 2009 Nov 18. Eur J Surg Oncol. 2010. PMID: 19926242

4

Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells.

Hoogwater FJ, Nijkamp MW, Smakman N, Steller EJ, Emmink BL, Westendorp BF, Raats DA, Sprick MR, Schaefer U, Van Houdt WJ, De Bruijn MT, Schackmann RC, Derksen PW, Medema JP, Walczak H, Borel Rinkes IH, Kranenburg O. Hoogwater FJ, et al. Among authors: van houdt wj. Gastroenterology. 2010 Jun;138(7):2357-67. doi: 10.1053/j.gastro.2010.02.046. Epub 2010 Feb 23. Gastroenterology. 2010. PMID: 20188103

5

Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa.

de Bruijn MT, Raats DA, Hoogwater FJ, van Houdt WJ, Cameron K, Medema JP, Borel Rinkes IH, Kranenburg O. de Bruijn MT, et al. Among authors: van houdt wj. Br J Cancer. 2010 Apr 13;102(8):1254-64. doi: 10.1038/sj.bjc.6605633. Epub 2010 Mar 30. Br J Cancer. 2010. PMID: 20354524 Free PMC article.

6

Oncogenic K-ras activates p38 to maintain colorectal cancer cell proliferation during MEK inhibition.

van Houdt WJ, de Bruijn MT, Emmink BL, Raats D, Hoogwater FJ, Borel Rinkes IH, Kranenburg O. van Houdt WJ, et al. Cell Oncol. 2010 Jan 1;32(4):245-57. doi: 10.3233/CLO-2010-0521. Cell Oncol. 2010. PMID: 20413844 Free PMC article.

7

Oncogenic KRAS desensitizes colorectal tumor cells to epidermal growth factor receptor inhibition and activation.

van Houdt WJ, Hoogwater FJ, de Bruijn MT, Emmink BL, Nijkamp MW, Raats DA, van der Groep P, van Diest P, Borel Rinkes IH, Kranenburg O. van Houdt WJ, et al. Among authors: van der groep p, van diest p. Neoplasia. 2010 Jun;12(6):443-52. doi: 10.1593/neo.92088. Neoplasia. 2010. PMID: 20563247 Free PMC article.

8

Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan.

Emmink BL, Van Houdt WJ, Vries RG, Hoogwater FJ, Govaert KM, Verheem A, Nijkamp MW, Steller EJ, Jimenez CR, Clevers H, Borel Rinkes IH, Kranenburg O. Emmink BL, et al. Among authors: van houdt wj. Gastroenterology. 2011 Jul;141(1):269-78. doi: 10.1053/j.gastro.2011.03.052. Epub 2011 Apr 1. Gastroenterology. 2011. PMID: 21459094

9

Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium.

Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, Van Houdt WJ, Pronk A, Van Gorp J, Siersema PD, Clevers H. Sato T, et al. Among authors: van houdt wj, van gorp j, van den brink s, van es jh. Gastroenterology. 2011 Nov;141(5):1762-72. doi: 10.1053/j.gastro.2011.07.050. Epub 2011 Sep 2. Gastroenterology. 2011. PMID: 21889923

10

Circulating CD95-ligand as a potential prognostic marker for recurrence in patients with synchronous colorectal liver metastases.

Hoogwater FJ, Snoeren N, Nijkamp MW, Gunning AC, VAN Houdt WJ, DE Bruijn MT, Voest EE, VAN Hillegersberg R, Kranenburg O, Rinkes IH. Hoogwater FJ, et al. Among authors: van houdt wj, van hillegersberg r. Anticancer Res. 2011 Dec;31(12):4507-12. Anticancer Res. 2011. PMID: 22199323

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

190 results

Search Page